BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35364414)

  • 1. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma.
    Komut N; Bektas S; Yildirim E
    Ann Diagn Pathol; 2022 Jun; 58():151933. PubMed ID: 35364414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
    Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
    J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlational research of Golgi phosphorylation protein 3 expression in colorectal cancer.
    Guo YT; Qiu CZ; Huang ZX; Yu WS; Yang XF; Wang MZ
    World J Gastroenterol; 2015 Dec; 21(48):13473-9. PubMed ID: 26730158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Budding and PDC Grade Are Stage Independent Predictors of Clinical Outcome in Mismatch Repair Deficient Colorectal Cancer.
    Ryan É; Khaw YL; Creavin B; Geraghty R; Ryan EJ; Gibbons D; Hanly A; Martin ST; O'Connell PR; Winter DC; Sheahan K
    Am J Surg Pathol; 2018 Jan; 42(1):60-68. PubMed ID: 29112018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Prognostic Impact of Tumor Border Configuration, Tumor Budding and Tumor Stroma Ratio in Colorectal Carcinoma.
    Aboelnasr LS; El-Rebey HS; Mohamed A; Abdou AG
    Turk Patoloji Derg; 2023; 39(1):83-93. PubMed ID: 35642343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumoral and Parenchymal Morphological Assessment in Liver Metastases of Colorectal Carcinoma: Micrometastasis, Peritumoral Lymphocytes, Tumor Budding and Differentiation are Potential Prognostic Factors.
    Aysal A; Agalar C; Egeli T; Ozbilgin M; Unek T; Somali I; Oztop I; Obuz F; Astarcioglu I; Sagol O
    Int J Surg Pathol; 2022 Dec; 30(8):861-871. PubMed ID: 35491669
    [No Abstract]   [Full Text] [Related]  

  • 7. Intratumoral budding as a potential parameter of tumor progression in mismatch repair-proficient and mismatch repair-deficient colorectal cancer patients.
    Lugli A; Vlajnic T; Giger O; Karamitopoulou E; Patsouris ES; Peros G; Terracciano LM; Zlobec I
    Hum Pathol; 2011 Dec; 42(12):1833-40. PubMed ID: 21664647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tumor budding in colorectal adenocarcinoma: Possible involvement of the intestinal cancer stem cell marker Lgr5.
    Sadek SA; A Rehim DM; Fatima S
    Indian J Pathol Microbiol; 2020; 63(1):32-37. PubMed ID: 32031119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Budding as a risk factor for lymph node metastasis in pT1 or pT2 well-differentiated colorectal adenocarcinoma.
    Okuyama T; Oya M; Ishikawa H
    Dis Colon Rectum; 2002 May; 45(5):628-34. PubMed ID: 12004212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma.
    Losi L; Ponti G; Gregorio CD; Marino M; Rossi G; Pedroni M; Benatti P; Roncucci L; de Leon MP
    Pathol Res Pract; 2006; 202(9):663-70. PubMed ID: 16860493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic and prognostic implications of Golgi Phosphoprotein 3 in colorectal cancer: A meta-analysis.
    Wang T; Fei J; Nie S
    PLoS One; 2021; 16(11):e0260035. PubMed ID: 34807928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-grade intratumoral tumor budding is a predictor for lymphovascular invasion and adverse outcome in stage II colorectal cancer.
    Marx AH; Mickler C; Sauter G; Simon R; Terracciano LM; Izbicki JR; Clauditz TS
    Int J Colorectal Dis; 2020 Feb; 35(2):259-268. PubMed ID: 31838579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Golgi phosphoprotein 3 expression predicts poor prognosis in patients with prostate cancer undergoing radical prostatectomy.
    Zhang L; Guo F; Gao X; Wu Y
    Mol Med Rep; 2015 Jul; 12(1):1298-304. PubMed ID: 25760033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between MLH-1, MSH-2, PMS-2,MSH-6 expression and clinicopathological features in colorectal cancer.
    Karahan B; Argon A; Yıldırım M; Vardar E
    Int J Clin Exp Pathol; 2015; 8(4):4044-53. PubMed ID: 26097592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
    Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
    Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors analysis of the early colorectal carcinoma after endoscopic non-curative resection: A retrospective clinical study of 56 cases].
    Wang R; Zhang Y; Dou L; Liu Y; He S; Liu X; Yu X; Wang G
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Aug; 20(8):923-927. PubMed ID: 28836256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GOLPH3 high expression predicts poor prognosis in patients with resected non-small cell lung cancer: an immunohistochemical analysis.
    Zhang Y; Ma M; Han B
    Tumour Biol; 2014 Nov; 35(11):10833-9. PubMed ID: 25081375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of Lymphatic Vessel Density Detected by D2-40 and Its Relation to Claudin-4 Expression in Prostatic Adenocarcinoma.
    Radi DA; Abd-Elazeem MA
    Int J Surg Pathol; 2016 May; 24(3):219-26. PubMed ID: 26464161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on independent factors on the prognosis of colorectal carcinoma: TNM stage, tumor budding, perineural invasion, peritumoral-lymphocytic infiltration and urine glucose].
    Xu FY; Dong JK; Zhu YM; Qu MJ; Wang FJ; Jin YS; Ren GP; Lai MD
    Zhonghua Liu Xing Bing Xue Za Zhi; 2005 May; 26(5):366-9. PubMed ID: 16053766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic relevance of histopathological features in signet ring cell carcinoma of the colorectum.
    Barresi V; Reggiani Bonetti L; Domati F; Baron L
    Virchows Arch; 2016 Sep; 469(3):267-75. PubMed ID: 27394431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.